MAY 15, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Lorazepam (Labeling)
U.S. Food and Drug Administration
This is an FDA supplemental approval action for lorazepam labeling; it documents a regulatory decision, not clinical evidence of efficacy or safety.
Reported
Approval date2026-05-15
Product strengths approved2 mg/mL and 4 mg/mL injectable formulations